The Global Cancer Landscape: From First- to Third-Generation Targeted Drugs — How Medicine Is Changing the Fate of CancerNot long ago, a cancer diagnosis was almost a death senten...
Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...